Trial Profile
A retrospective study of bisphosphonates and denosumab in children with Osteogenesis imperfecta
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteogenesis imperfecta
- Focus Therapeutic Use
- 03 Jan 2017 New trial record